In 2023, Kenya set an ambitious target of ensuring that 50 percent of essential medicines are sourced from local manufacturers by 2026, as part of a broader strategy to achieve universal health coverage while reducing reliance on costly imports and strengthening the local pharmaceutical industry.
According to the government, the initiative aims to reduce the country's annual import bill by Sh76 billion, increase export earnings, create more job opportunities, and promote long-term economic growth.
